文献速递中医内科中药与中成药合理使用

丹参酚酸注射剂抗缺血性脑卒中机制的计算预测与实验验证

Exploration of the Mechanism of Salvianolic Acid for Injection Against Ischemic Stroke: A Research Based on Computational Prediction and Experimental Validation.
PubMed 文献 · Front Pharmacol · 2022-05-25

研究以丹参酚酸注射剂(SAFI)为对象,采用计算系统药理学方法,将文献挖掘与数据库检索获得的SAFI潜在靶点与缺血性脑卒中相关基因比对,得到38个共同基因,涉及炎症反应相关通路,提示SAFI可能发挥抗炎作用。体外实验初步验证SAFI以剂量依赖方式抑制PTGS1与PTGS2活性,并抑制脂多糖诱导的RAW264.7巨噬细胞与BV-2小胶质细胞前列腺素E2生成。

要点

  • SAFI潜在靶点与缺血性脑卒中相关基因交集为38个,涉及炎症反应通路。
  • 体外验证显示SAFI剂量依赖性抑制PTGS1与PTGS2活性。
  • SAFI抑制脂多糖诱导的RAW264.7与BV-2细胞前列腺素E2生成。

核心结论

  • SAFI可能通过抗炎机制作用于缺血性脑卒中,PTGS1与PTGS2为其受抑制的相关靶点。
  • 该研究提示计算系统药理学结合体外验证是阐明中药作用机制的可行途径。

研究设计与样本

  • 基于计算系统药理学分析,通过文献挖掘与数据库检索获取SAFI潜在靶点,并与缺血性脑卒中相关基因比对。
  • 体外初步验证SAFI对PTGS1、PTGS2活性及脂多糖诱导的前列腺素E2生成的影响,使用RAW264.7巨噬细胞与BV-2小胶质细胞。

主要发现

  • SAFI潜在靶点与缺血性脑卒中相关基因比对得到38个共同基因,相关通路涉及炎症反应。
  • SAFI以剂量依赖方式抑制PTGS1和PTGS2活性。
  • SAFI抑制脂多糖诱导的RAW264.7巨噬细胞与BV-2小胶质细胞前列腺素E2产生。

临床怎么用

  • 结果支持SAFI在缺血性脑卒中中可能通过抗炎途径发挥作用,为临床应用提供机制层面的参考。
  • PTGS1、PTGS2及前列腺素E2可作为后续研究SAFI抗炎作用的相关指标。

局限性

  • 机制结论主要基于计算预测与体外初步验证,尚需进一步体内研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic stroke (IS) is an acute neurological injury that occurs when a vessel supplying blood to the brain is obstructed, which is a leading cause of death and disability. Salvia miltiorrhiza has been used in the treatment of cardiovascular and cerebrovascular diseases for over thousands of years due to its effect activating blood circulation and dissipating blood stasis. However, the herbal preparation is chemically complex and the diversity of potential targets makes difficult to determine its mechanism of action. To gain insight into its mechanism of action, we analyzed "Salvianolic acid for injection" (SAFI), a traditional Chinese herbal medicine with anti-IS effects, using computational systems pharmacology. The potential targets of SAFI, obtained from literature mining and database searches, were compared with IS-associated genes, giving 38 common genes that were related with pathways involved in inflammatory response. This suggests that SAFI might function as an anti-inflammatory agent. Two genes associated with inflammation (PTGS1 and PTGS2), which were inhibited by SAFI, were preliminarily validated in vitro. The results showed that SAFI inhibited PTGS1 and PTGS2 activity in a dose-dependent manner and inhibited the production of prostaglandin E2 induced by lipopolysaccharide in RAW264.7 macrophages and BV-2 microglia. This approach reveals the possible pharmacological mechanism of SAFI acting on IS, and also provides a feasible way to elucidate the mechanism of traditional Chinese medicine (TCM).

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li X, Guo K, Zhang R, et al. Exploration of the Mechanism of Salvianolic Acid for Injection Against Ischemic Stroke: A Research Based on Computational Prediction and Experimental Validation. Front Pharmacol. 2022. PMID: 35694259. doi:10.3389/fphar.2022.894427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。